C4 Therapeutics, Inc. ( CCCC) - Key Metrics
CCCC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.13 | -$0.25 | -$0.27 | -$0.27 |
| 2025Q3 | $0.15 | -$0.44 | -$0.43 | -$0.44 |
| 2025Q1 | $0.09 | -$0.37 | -$0.17 | -$0.17 |
| 2024Q4 | $0.10 | -$0.37 | -$0.47 | -$0.47 |
CCCC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.93 |
| 2025Q3 | ? | -1.25 |
| 2025Q1 | ? | -0.98 |
| 2024Q4 | ? | -1.08 |
CCCC
Price: $4.30
52 week price:
Earnings Per Share: -1.10 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 914600
Market Capitalization: 357.1 million